Literature DB >> 10221324

Standardized lifetime risk.

P D Sasieni1, J Adams.   

Abstract

The authors propose the use of two new standardized measures of risk, the standardized lifetime risk and the standardized number of years of life lost. These measures maintain the advantages of standardized rates but are more readily understood without special training. In this paper, standardizing weights based on 1992 data from England and Wales are provided, and the new measures are illustrated with a variety of examples. The new standardized rates are useful for examining trends over time; for comparing the impact of various diseases on public health; and for comparing rates of a given disease in several different countries. The authors think it is far more informative to say that 41 out of every 1,000 women die of breast cancer than to say that the standardized mortality rate is 51 per 100,000 women per year.

Entities:  

Mesh:

Year:  1999        PMID: 10221324     DOI: 10.1093/oxfordjournals.aje.a009903

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  13 in total

1.  Inequalities in health. Analytic approaches based on life expectancy and suitable for small area comparisons.

Authors:  P J Veugelers; A L Kim; J R Guernsey
Journal:  J Epidemiol Community Health       Date:  2000-05       Impact factor: 3.710

2.  Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs.

Authors:  Simopekka Vänskä; Tapio Luostarinen; Camilla Lagheden; Carina Eklund; Sara Nordqvist Kleppe; Bengt Andrae; Pär Sparén; Karin Sundström; Matti Lehtinen; Joakim Dillner
Journal:  Am J Epidemiol       Date:  2021-04-06       Impact factor: 4.897

3.  RiskDiff: a web tool for the analysis of the difference due to risk and demographic factors for incidence or mortality data.

Authors:  Joan Valls; Ramon Clèries; Jordi Gálvez; Victor Moreno; Rosa Gispert; Josep M Borràs; Josepa Ribes
Journal:  BMC Public Health       Date:  2009-12-18       Impact factor: 3.295

4.  Lifetime Risk and Risk Factors for Abdominal Aortic Aneurysm in a 24-Year Prospective Study: The ARIC Study (Atherosclerosis Risk in Communities).

Authors:  Weihong Tang; Lu Yao; Nicholas S Roetker; Alvaro Alonso; Pamela L Lutsey; Carol C Steenson; Frank A Lederle; David W Hunter; Lindsay G S Bengtson; Weihua Guan; Emil Missov; Aaron R Folsom
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-11-10       Impact factor: 8.311

5.  Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.

Authors:  Ramachandran S Vasan; Danielle M Enserro; Vanessa Xanthakis; Alexa S Beiser; Sudha Seshadri
Journal:  Circulation       Date:  2022-04-18       Impact factor: 39.918

6.  Lifetime Risk of Venous Thromboembolism in Two Cohort Studies.

Authors:  Elizabeth J Bell; Pamela L Lutsey; Saonli Basu; Mary Cushman; Susan R Heckbert; Donald M Lloyd-Jones; Aaron R Folsom
Journal:  Am J Med       Date:  2015-11-18       Impact factor: 4.965

7.  Lifetime Risk of Heart Failure Among Participants in the Framingham Study.

Authors:  Ramachandran S Vasan; Danielle M Enserro; Alexa S Beiser; Vanessa Xanthakis
Journal:  J Am Coll Cardiol       Date:  2022-01-25       Impact factor: 24.094

8.  The epidemiology of appendicitis and appendectomy in South Korea: national registry data.

Authors:  Jung Hun Lee; Young Sun Park; Joong Sub Choi
Journal:  J Epidemiol       Date:  2009-12-19       Impact factor: 3.211

9.  The Risk of Cancer Might be Lower Than We Think. Alternatives to Lifetime Risk Estimates.

Authors:  Gilat L Grunau; Shay Gueron; Boris Pornov; Shai Linn
Journal:  Rambam Maimonides Med J       Date:  2018-01-29

10.  What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries.

Authors:  P D Sasieni; J Shelton; N Ormiston-Smith; C S Thomson; P B Silcocks
Journal:  Br J Cancer       Date:  2011-07-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.